{"transactions":[{"id":4628722,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-10-02T23:00:09.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":3766,"derivative":{"exercise_price":3.55,"expiration_date":"2036-09-29","underlying":"Common Stock","underlying_shares":3766},"source":{"system":"sec-edgar","filing":"0001104659-26-113412","document":"tm2626853-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926113412/tm2626853-1_4seq1.xml","form_type":"4"}},{"id":719138,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-07-02T23:00:18.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":4595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended June 30, 2026, the reporting person was granted non-statutory stock options to purchase 4,595 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":4595,"derivative":{"exercise_price":3.67,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":4595},"source":{"system":"sec-edgar","filing":"0001104659-26-080466","document":"tm2619589-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000110465926080466/tm2619589-1_4seq1.xml","form_type":"4"}},{"id":820994,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-04-02T23:00:18.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":3024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended March 31, 2026, the reporting person was granted non-statutory stock options to purchase 3,024 shares of common stock under the ClearSign Technologies Corporation 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":3024,"derivative":{"exercise_price":4.36,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":3024},"source":{"system":"sec-edgar","filing":"0001104659-26-039309","document":"tm2610943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000110465926039309/tm2610943-1_4seq1.xml","form_type":"4"}},{"id":932646,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-24T00:44:04.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":60324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":136589,"source":{"system":"sec-edgar","filing":"0001193125-26-021415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000119312526021415/ownership.xml","form_type":"4"}},{"id":1018815,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-10-16T01:54:17.000Z","date":"2025-10-10","kind":"grant","planned":false,"acquired":true,"shares":141644,"price":7.06,"value":1000006.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock."}],"balance_after":141644,"derivative":{"exercise_price":6.81,"exercise_date":"2025-10-15","expiration_date":"2030-10-15","underlying":"Common Stock","underlying_shares":141644},"source":{"system":"sec-edgar","filing":"0001193125-25-240662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000119312525240662/ownership.xml","form_type":"4"}},{"id":1018814,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T01:54:17.000Z","date":"2025-10-10","kind":"grant","planned":false,"acquired":true,"shares":70822,"price":7.06,"value":500003.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested restricted stock units."}],"balance_after":76265,"source":{"system":"sec-edgar","filing":"0001193125-25-240662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000119312525240662/ownership.xml","form_type":"4"}},{"id":1071666,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option","published_at":"2025-08-08T23:18:26.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027."},{"field":"security","element":"securityTitle","label":"F2","text":"500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share."}],"balance_after":900000,"derivative":{"exercise_price":4.25,"exercise_date":"2025-04-28","expiration_date":"2035-04-28","underlying":"Class A","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001641172-25-022846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225022846/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-28"}},{"id":1071665,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"RSU","published_at":"2025-08-08T23:18:26.000Z","date":"2025-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-04-28","expiration_date":"2025-04-28","underlying":"Class A","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001641172-25-022846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225022846/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-28"}},{"id":1071663,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T23:09:05.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":1425,"price":4.9,"value":6982.5,"ownership":{"direct":true},"balance_after":95699,"source":{"system":"sec-edgar","filing":"0001641172-25-022844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225022844/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-07"}},{"id":1098313,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-01T10:25:00.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":5384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026."}],"balance_after":5443,"source":{"system":"sec-edgar","filing":"0000950170-25-091885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000095017025091885/ownership.xml","form_type":"4"}},{"id":1164305,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Employee Stock Option","published_at":"2025-04-30T01:01:51.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027."},{"field":"security","element":"securityTitle","label":"F2","text":"500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share."}],"balance_after":900000,"derivative":{"exercise_price":4.25,"exercise_date":"2025-04-28","expiration_date":"2035-04-28","underlying":"Class A","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001641172-25-006734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225006734/ownership.xml","form_type":"4"}},{"id":1164304,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"RSU","published_at":"2025-04-30T01:01:51.000Z","date":"2025-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-04-28","expiration_date":"2025-04-28","underlying":"Class A","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001641172-25-006734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225006734/ownership.xml","form_type":"4"}},{"id":1174901,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-04-09T22:21:06.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":1425,"price":4.9,"value":6982.5,"ownership":{"direct":true},"balance_after":95699,"source":{"system":"sec-edgar","filing":"0001641172-25-003465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000164117225003465/ownership.xml","form_type":"4"}},{"id":1268072,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-15T00:21:25.000Z","date":"2025-02-13","kind":"purchase","planned":false,"acquired":true,"shares":942,"price":6.15,"value":5793.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 13, 2025 were purchased in multiple transactions at prices ranging from $6.10 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":94274,"source":{"system":"sec-edgar","filing":"0001493152-25-007022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225007022/ownership.xml","form_type":"4"}},{"id":1268071,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-15T00:21:25.000Z","date":"2025-02-12","kind":"purchase","planned":false,"acquired":true,"shares":290,"price":6.15,"value":1783.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 12, 2025 were purchased in multiple transactions at prices ranging from $6.13 to $6.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93332,"source":{"system":"sec-edgar","filing":"0001493152-25-007022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225007022/ownership.xml","form_type":"4"}},{"id":1274744,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-11T23:48:04.000Z","date":"2025-02-11","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.22,"value":6220.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 11, 2025 were purchased in multiple transactions at prices ranging from $6.21 to $6.24 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93042,"source":{"system":"sec-edgar","filing":"0001493152-25-005974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225005974/ownership.xml","form_type":"4"}},{"id":1274743,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-11T23:48:04.000Z","date":"2025-02-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.22,"value":6220.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 7, 2025 were purchased in multiple transactions at prices ranging from $6.21 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92042,"source":{"system":"sec-edgar","filing":"0001493152-25-005974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225005974/ownership.xml","form_type":"4"}},{"id":1280661,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-06T21:50:06.000Z","date":"2025-02-05","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":6.24,"value":1872.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 5, 2025 were purchased in multiple transactions at prices ranging from $6.23 to $6.24 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":91042,"source":{"system":"sec-edgar","filing":"0001493152-25-005217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225005217/ownership.xml","form_type":"4"}},{"id":1280660,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-06T21:50:06.000Z","date":"2025-02-04","kind":"purchase","planned":false,"acquired":true,"shares":398,"price":6.22,"value":2475.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 4, 2025 were purchased in multiple transactions at prices ranging from $6.15 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":90742,"source":{"system":"sec-edgar","filing":"0001493152-25-005217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225005217/ownership.xml","form_type":"4"}},{"id":1287919,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-03T22:23:55.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.17,"value":6170.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 3, 2025 were purchased in multiple transactions at prices ranging from $6.12 to $6.17 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":90344,"source":{"system":"sec-edgar","filing":"0001493152-25-004705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225004705/ownership.xml","form_type":"4"}},{"id":1287918,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-03T22:23:55.000Z","date":"2025-01-31","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.2,"value":6200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 31, 2025 were purchased in multiple transactions at prices ranging from $6.19 to $6.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":89344,"source":{"system":"sec-edgar","filing":"0001493152-25-004705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225004705/ownership.xml","form_type":"4"}},{"id":1287917,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-02-03T22:23:55.000Z","date":"2025-01-30","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":6.22,"value":622.0,"ownership":{"direct":true},"balance_after":88344,"source":{"system":"sec-edgar","filing":"0001493152-25-004705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225004705/ownership.xml","form_type":"4"}},{"id":1292128,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-29T23:16:07.000Z","date":"2025-01-29","kind":"purchase","planned":false,"acquired":true,"shares":14,"price":6.21,"value":86.94,"ownership":{"direct":true},"balance_after":88244,"source":{"system":"sec-edgar","filing":"0001493152-25-004196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225004196/ownership.xml","form_type":"4"}},{"id":1292127,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-29T23:16:07.000Z","date":"2025-01-27","kind":"purchase","planned":false,"acquired":true,"shares":933,"price":6.21,"value":5793.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 27, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.21 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":88230,"source":{"system":"sec-edgar","filing":"0001493152-25-004196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225004196/ownership.xml","form_type":"4"}},{"id":1294735,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-27T20:38:52.000Z","date":"2025-01-24","kind":"purchase","planned":false,"acquired":true,"shares":164,"price":6.21,"value":1018.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 24, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":87297,"source":{"system":"sec-edgar","filing":"0001493152-25-003772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003772/ownership.xml","form_type":"4"}},{"id":1294734,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-27T20:38:52.000Z","date":"2025-01-23","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":6.24,"value":1248.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 23, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":87133,"source":{"system":"sec-edgar","filing":"0001493152-25-003772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003772/ownership.xml","form_type":"4"}},{"id":1294733,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-27T20:38:52.000Z","date":"2025-01-22","kind":"purchase","planned":false,"acquired":true,"shares":928,"price":6.21,"value":5762.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 22, 2025 were purchased in multiple transactions at prices ranging from $6.15 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":86933,"source":{"system":"sec-edgar","filing":"0001493152-25-003772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003772/ownership.xml","form_type":"4"}},{"id":1299094,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-22T02:40:15.000Z","date":"2025-01-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.21,"value":6210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 21, 2025 were purchased in multiple transactions at prices ranging from $6.13 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":86005,"source":{"system":"sec-edgar","filing":"0001493152-25-003127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003127/ownership.xml","form_type":"4"}},{"id":1299093,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-22T02:40:15.000Z","date":"2025-01-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.1,"value":6100.0,"ownership":{"direct":true},"balance_after":85005,"source":{"system":"sec-edgar","filing":"0001493152-25-003127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003127/ownership.xml","form_type":"4"}},{"id":1299092,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-22T02:40:15.000Z","date":"2025-01-16","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":6.23,"value":5607.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 16, 2025 were purchased in multiple transactions at prices ranging from $6.18 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":84005,"source":{"system":"sec-edgar","filing":"0001493152-25-003127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225003127/ownership.xml","form_type":"4"}},{"id":1302847,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-15T23:28:27.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.04,"value":6040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 15, 2025 were purchased in multiple transactions at prices ranging from $5.93 to $6.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":83709,"source":{"system":"sec-edgar","filing":"0001493152-25-002446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225002446/ownership.xml","form_type":"4"}},{"id":1302846,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-15T23:28:27.000Z","date":"2025-01-14","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.17,"value":6170.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 14, 2025 were purchased in multiple transactions at prices ranging from $6.08 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":82.709,"source":{"system":"sec-edgar","filing":"0001493152-25-002446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225002446/ownership.xml","form_type":"4"}},{"id":1302845,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-15T23:28:27.000Z","date":"2025-01-13","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.23,"value":6230.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 13, 2025 were purchased in multiple transactions at prices ranging from $6.10 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":81709,"source":{"system":"sec-edgar","filing":"0001493152-25-002446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225002446/ownership.xml","form_type":"4"}},{"id":1308818,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2025-01-08T01:20:19.000Z","date":"2025-01-03","kind":"purchase","planned":false,"acquired":true,"shares":16,"price":6.25,"value":100.0,"ownership":{"direct":true},"balance_after":80709,"source":{"system":"sec-edgar","filing":"0001493152-25-001272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315225001272/ownership.xml","form_type":"4"}},{"id":1320574,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-30T18:23:06.000Z","date":"2024-12-20","kind":"purchase","planned":false,"acquired":true,"shares":355,"price":6.25,"value":2218.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 20, 2024 were purchased in multiple transactions at prices ranging from $6.21 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":80693,"source":{"system":"sec-edgar","filing":"0001493152-24-052434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224052434/ownership.xml","form_type":"4/A","original_submission_date":"2024-12-23"}},{"id":1323280,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-23T23:54:02.000Z","date":"2024-12-20","kind":"purchase","planned":false,"acquired":false,"shares":355,"price":6.25,"value":2218.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 20, 2024 were purchased in multiple transactions at prices ranging from $6.21 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":80693,"source":{"system":"sec-edgar","filing":"0001493152-24-051920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224051920/ownership.xml","form_type":"4"}},{"id":1324639,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-20T17:36:47.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":false,"shares":1000,"price":6.24,"value":6240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 19, 2024 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":80338,"source":{"system":"sec-edgar","filing":"0001493152-24-050941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224050941/ownership.xml","form_type":"4"}},{"id":1324638,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-20T17:36:47.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":false,"shares":1000,"price":6.2,"value":6200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 18, 2024 were purchased in multiple transactions at prices ranging from $6.12 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":79338,"source":{"system":"sec-edgar","filing":"0001493152-24-050941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224050941/ownership.xml","form_type":"4"}},{"id":1324637,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-20T17:36:47.000Z","date":"2024-12-17","kind":"purchase","planned":false,"acquired":false,"shares":1693,"price":6.21,"value":10513.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 17, 2024 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":78338,"source":{"system":"sec-edgar","filing":"0001493152-24-050941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224050941/ownership.xml","form_type":"4"}},{"id":1324636,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"RSU","published_at":"2024-12-20T17:36:45.000Z","date":"2024-10-21","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":400000,"derivative":{"exercise_price":0,"exercise_date":"2024-10-21","expiration_date":"2024-10-21","underlying":"Class A","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-24-050943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224050943/ownership.xml","form_type":"4"}},{"id":1324635,"issuer":{"id":7469,"kind":"organization","name":"MDB Capital Holdings, LLC"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Founder"}}],"security":"Common Stock","published_at":"2024-12-20T17:36:45.000Z","date":"2024-10-21","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":6.81,"value":340500.0,"ownership":{"direct":true},"balance_after":76645,"source":{"system":"sec-edgar","filing":"0001493152-24-050943","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315224050943/ownership.xml","form_type":"4"}},{"id":1623247,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-23T22:00:39.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025."}],"balance_after":600,"derivative":{"exercise_price":1.59,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001209191-24-003901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919124003901/doc4.xml","form_type":"4"}},{"id":1906783,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2023-05-03T20:07:29.000Z","date":"2023-05-02","kind":"purchase","planned":false,"acquired":true,"shares":41667,"price":0.01,"value":416.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents warrants purchased in the Offering. The warrants were offered and sold at the rate of one warrant to purchase one share for every two shares of common stock purchased in the Offering."}],"balance_after":41667,"derivative":{"exercise_price":1.4,"exercise_date":"2023-05-02","expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001209191-23-026925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919123026925/doc4.xml","form_type":"4"}},{"id":1906782,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:07:29.000Z","date":"2023-05-02","kind":"purchase","planned":false,"acquired":true,"shares":83333,"price":1.2,"value":99999.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased in the Registrant's underwritten public offering that closed May 2, 2023 (the \"Offering\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering."}],"balance_after":102434,"source":{"system":"sec-edgar","filing":"0001209191-23-026925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919123026925/doc4.xml","form_type":"4"}},{"id":2038974,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-02-02T01:30:27.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":9621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024."}],"balance_after":9621,"derivative":{"exercise_price":4.02,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":9621},"source":{"system":"sec-edgar","filing":"0001209191-23-006049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919123006049/doc4.xml","form_type":"4"}},{"id":2314394,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-30T21:15:34.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":109323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023."}],"balance_after":109323,"derivative":{"exercise_price":0.38,"expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":109323},"source":{"system":"sec-edgar","filing":"0001209191-22-021621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919122021621/doc4.xml","form_type":"4"}},{"id":2450880,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-01-04T22:06:24.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.74,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-000957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919122000957/doc4.xml","form_type":"4"}},{"id":2754708,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-04-07T20:15:10.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2031-04-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-025859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919121025859/doc4.xml","form_type":"4"}},{"id":2772302,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-03-25T21:00:45.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 4, 2021 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919121023038/doc4.xml","form_type":"4"}},{"id":3077100,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2020-07-23T12:00:08.000Z","date":"2020-07-21","kind":"other","acquired":false,"shares":100503,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.87,"exercise_date":"2019-12-10","expiration_date":"2024-12-11","underlying":"Common Stock","underlying_shares":100503},"source":{"system":"sec-edgar","filing":"0001209191-20-043430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120043430/doc4.xml","form_type":"4"}},{"id":3077099,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T12:00:08.000Z","date":"2020-07-21","kind":"other","acquired":true,"shares":100503,"price":0.87,"value":87437.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Included unvested restricted stock units."}],"balance_after":382012,"source":{"system":"sec-edgar","filing":"0001209191-20-043430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120043430/doc4.xml","form_type":"4"}},{"id":3117226,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T11:27:45.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":5000,"price":0.92,"value":4600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.94, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":281509,"source":{"system":"sec-edgar","filing":"0001209191-20-035185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120035185/doc4.xml","form_type":"4"}},{"id":3131094,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T10:49:56.000Z","date":"2020-05-28","kind":"purchase","acquired":true,"shares":5000,"price":0.9,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.94, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The balance reflects an adjustment to correct a computational error in column 5 of the reporting person's Form 4 filed December 11, 2019, which stated 199,226 but should have stated 218,652."}],"balance_after":276509,"source":{"system":"sec-edgar","filing":"0001209191-20-032827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120032827/doc4.xml","form_type":"4"}},{"id":3135671,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T11:03:38.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":10000,"price":0.78,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.74 to $0.81, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":252083,"source":{"system":"sec-edgar","filing":"0001209191-20-031895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120031895/doc4.xml","form_type":"4"}},{"id":3178158,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T20:42:38.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":42857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":242083,"source":{"system":"sec-edgar","filing":"0001209191-20-024215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120024215/doc4.xml","form_type":"4"}},{"id":3319370,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-01-06T21:19:18.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":1.9,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-001778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919120001778/doc4.xml","form_type":"4"}},{"id":3345682,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2019-12-11T22:48:10.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":100503,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Warrants were issued for no additional consideration in connection with the purchase of the common stock."}],"balance_after":100503,"derivative":{"exercise_price":0.87,"exercise_date":"2019-12-10","expiration_date":"2024-12-11","underlying":"Common Stock","underlying_shares":100503},"source":{"system":"sec-edgar","filing":"0001209191-19-060084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119060084/doc4.xml","form_type":"4"}},{"id":3345681,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-12-11T22:48:10.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":89585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date."}],"balance_after":89585,"derivative":{"exercise_price":0.9,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":89585},"source":{"system":"sec-edgar","filing":"0001209191-19-060084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119060084/doc4.xml","form_type":"4"}},{"id":3345680,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T22:48:10.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":100503,"price":0.87,"value":87437.61,"ownership":{"direct":true},"balance_after":199226,"source":{"system":"sec-edgar","filing":"0001209191-19-060084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119060084/doc4.xml","form_type":"4"}},{"id":3350326,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T22:26:58.000Z","date":"2019-12-03","kind":"other","acquired":true,"shares":342000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from MDB Capital Group LLC, of which the reporting person is a minority owner."}],"balance_after":520712,"source":{"system":"sec-edgar","filing":"0001493152-19-018862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219018862/ownership.xml","form_type":"4"}},{"id":3404724,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-30T21:00:14.000Z","date":"2019-09-30","kind":"purchase","acquired":true,"shares":30000,"price":6.83,"value":204900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.83 to $6.85, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":178712,"source":{"system":"sec-edgar","filing":"0001493152-19-014772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219014772/ownership.xml","form_type":"4"}},{"id":3405932,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-26T22:08:54.000Z","date":"2019-09-26","kind":"purchase","acquired":true,"shares":5000,"price":8.44,"value":42200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.30 to $8.78, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":148712,"source":{"system":"sec-edgar","filing":"0001493152-19-014640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219014640/ownership.xml","form_type":"4"}},{"id":3406544,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-25T21:45:47.000Z","date":"2019-09-25","kind":"purchase","acquired":true,"shares":5000,"price":8.39,"value":41950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.36 to $8.41, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":143712,"source":{"system":"sec-edgar","filing":"0001493152-19-014570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219014570/ownership.xml","form_type":"4"}},{"id":3442617,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T10:01:58.000Z","date":"2019-08-08","kind":"purchase","acquired":true,"shares":10000,"price":9.09,"value":90900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.96 to $9.18, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":138712,"source":{"system":"sec-edgar","filing":"0001493152-19-011940","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219011940/ownership.xml","form_type":"4"}},{"id":3479281,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-06-25T21:00:12.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vests on May 28, 2020."}],"balance_after":24000,"derivative":{"exercise_price":12.54,"expiration_date":"2029-06-24","underlying":"Common Stock, par value $0.0001","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-19-009704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219009704/ownership.xml","form_type":"4"}},{"id":3483076,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-20T21:37:21.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":10000,"price":10.96,"value":109600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.82 to $11.09, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":128712,"source":{"system":"sec-edgar","filing":"0001493152-19-009515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219009515/ownership.xml","form_type":"4"}},{"id":3486708,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T01:00:11.000Z","date":"2019-06-18","kind":"purchase","acquired":true,"shares":10000,"price":10.88,"value":108800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.84 to $10.89, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":118712,"source":{"system":"sec-edgar","filing":"0001493152-19-009410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219009410/ownership.xml","form_type":"4"}},{"id":3488391,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T22:00:11.000Z","date":"2019-06-17","kind":"purchase","acquired":true,"shares":25000,"price":12.16,"value":304000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.77 to $12.72, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":108712,"source":{"system":"sec-edgar","filing":"0001493152-19-009336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315219009336/ownership.xml","form_type":"4"}},{"id":3577339,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-28T00:06:03.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on March 25, 2019 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 25, 2020."}],"balance_after":50000,"derivative":{"exercise_price":3.09,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-021518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119021518/doc4.xml","form_type":"4"}},{"id":3705413,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T23:21:42.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":10000,"price":4.81,"value":48100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.94, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held jointly with the reporting person's spouse."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-19-002244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119002244/doc4.xml","form_type":"4"}},{"id":3710106,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-03T23:36:02.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":5.16,"exercise_date":"2020-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-001321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119001321/doc4.xml","form_type":"4"}},{"id":3714566,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T21:18:40.000Z","date":"2018-12-28","kind":"purchase","acquired":true,"shares":7000,"price":4.62,"value":32340.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.56 to $4.70, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held jointly with the reporting person's spouse."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0001209191-19-000261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919119000261/doc4.xml","form_type":"4"}},{"id":3716345,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-31T23:00:43.000Z","date":"2018-12-28","kind":"purchase","acquired":true,"shares":10000,"price":1.76,"value":17600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.73 to $1.81, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":83712,"source":{"system":"sec-edgar","filing":"0001493152-18-018149","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218018149/ownership.xml","form_type":"4"}},{"id":3717005,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T23:00:26.000Z","date":"2018-12-27","kind":"purchase","acquired":true,"shares":20000,"price":1.95,"value":39000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $2.13, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":73712,"source":{"system":"sec-edgar","filing":"0001493152-18-018087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218018087/ownership.xml","form_type":"4"}},{"id":3717004,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T13:40:49.000Z","date":"2018-12-27","kind":"purchase","acquired":true,"shares":20000,"price":4.77,"value":95400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.63 to $4.93, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held jointly with the reporting person's spouse."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-18-064233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118064233/doc4.xml","form_type":"4"}},{"id":3718372,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-27T23:00:16.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":17270,"price":1.92,"value":33158.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.82 to $1.99, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":53712,"source":{"system":"sec-edgar","filing":"0001493152-18-018017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218018017/ownership.xml","form_type":"4"}},{"id":3719880,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-26T23:00:14.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":2000,"price":1.85,"value":3700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.76 to $1.89, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":36442,"source":{"system":"sec-edgar","filing":"0001493152-18-017965","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218017965/ownership.xml","form_type":"4"}},{"id":3719879,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-26T21:07:51.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":10000,"price":4.49,"value":44900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.34 to $4.66, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held jointly with the reporting person's spouse."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-18-064085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118064085/doc4.xml","form_type":"4"}},{"id":3722337,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T23:00:17.000Z","date":"2018-12-20","kind":"purchase","acquired":true,"shares":5000,"price":1.96,"value":9800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $1.99, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":34442,"source":{"system":"sec-edgar","filing":"0001493152-18-017874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218017874/ownership.xml","form_type":"4"}},{"id":3727684,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T21:31:22.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":10000,"price":5.48,"value":54800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.57, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held jointly with the reporting person's spouse."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-063198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118063198/doc4.xml","form_type":"4"}},{"id":3742108,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-06T23:00:37.000Z","date":"2018-12-03","kind":"purchase","acquired":true,"shares":4442,"price":2.45,"value":10882.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.23 to $2.58, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":29442,"source":{"system":"sec-edgar","filing":"0001493152-18-017143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218017143/ownership.xml","form_type":"4"}},{"id":3746443,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-04T00:13:42.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":4849,"price":2.45,"value":11880.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.37 to $2.49, inclusive."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-18-016978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218016978/ownership.xml","form_type":"4"}},{"id":3746442,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-04T00:13:42.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":151,"price":2.47,"value":372.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.44 to $2.48, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":20151,"source":{"system":"sec-edgar","filing":"0001493152-18-016978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218016978/ownership.xml","form_type":"4"}},{"id":3750894,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-28T23:11:27.000Z","date":"2018-11-27","kind":"purchase","acquired":true,"shares":10000,"price":2.46,"value":24600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.38 to $2.54, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-18-016826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218016826/ownership.xml","form_type":"4"}},{"id":3752292,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-27T23:00:14.000Z","date":"2018-11-26","kind":"purchase","acquired":true,"shares":10000,"price":2.65,"value":26500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.73, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-18-016761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218016761/ownership.xml","form_type":"4"}},{"id":3763527,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-11-15T21:16:15.000Z","date":"2018-11-13","kind":"exercise","acquired":false,"price":100000,"reported_value":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Convertible Promissory Note (the \"Note\"), the principal amount of the Note automatically converted into shares of the Issuer's Common Stock upon the consummation of a Qualified Financing (as defined in the Note) at the lowest per share price at which Common Stock was sold by the Issuer in the Qualified Financing, less a discount of 20%."}],"derivative":{"exercise_price":1.68,"expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":59524},"source":{"system":"sec-edgar","filing":"0001209191-18-058718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118058718/doc4.xml","form_type":"4"}},{"id":3763526,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-15T21:16:15.000Z","date":"2018-11-13","kind":"exercise","acquired":true,"shares":59524,"price":1.68,"value":100000.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of Common Stock were issued upon the conversion of the Convertible Promissory Note described in footnote (2)."}],"balance_after":118149,"source":{"system":"sec-edgar","filing":"0001209191-18-058718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118058718/doc4.xml","form_type":"4"}},{"id":3864799,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-07-19T21:54:37.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":128981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's 2017 Equity Incentive Plan, effective as of the closing of the Issuer's initial public offering of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in eight equal semi-annual installments commencing on January 19, 2018 and will become fully vested on July 19, 2022."}],"balance_after":128981,"derivative":{"exercise_price":4,"expiration_date":"2028-07-19","underlying":"Common Stock, par value $0.0001","underlying_shares":128981},"source":{"system":"sec-edgar","filing":"0001493152-18-010230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000149315218010230/ownership.xml","form_type":"4"}},{"id":3879272,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-02T23:39:00.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":24802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Warrants were issued for no additional consideration in connection with the offer and sale of the Note."}],"balance_after":24802,"derivative":{"exercise_price":2.52,"exercise_date":"2018-12-28","expiration_date":"2021-06-28","underlying":"Common Stock","underlying_shares":24802},"source":{"system":"sec-edgar","filing":"0001209191-18-040510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118040510/doc4.xml","form_type":"4"}},{"id":3879271,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-07-02T23:39:00.000Z","date":"2018-06-28","kind":"grant","acquired":true,"price":100000,"reported_value":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Convertible Promissory Note (the \"Note\") is convertible into the Issuer's common stock at a conversion price equal to the lesser of (a) the lowest per share price at which common stock is sold by the Issuer in a sale resulting in aggregate gross cash proceeds of at least $7.0 million (a \"Qualified Financing\"), less a discount of 20%, or (b) $2.016, but in any event no less than a conversion price floor of $1.40, which conversion price is subject to adjustment in certain circumstances in accordance with the terms of the Note."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The principal amount of the Note will automatically convert into shares of the Issuer's common stock (i) upon the consummation of a Qualified Financing or (ii) if the holders of a majority of the aggregate principal amount of outstanding Convertible Promissory Notes elect to convert such notes at any time until three days prior to a Qualified Financing. Additionally, the reporting person is entitled to convert the principal amount of the Note into common stock (i) at any time until three days prior to the consummation of a Qualified Financing or (ii) if a material Event of Default (as defined in the Note) shall have occurred and be continuing. In each case, conversion is subject to the terms and provisions of the Note."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of shares of common stock shown in Column 7 assumes a conversion price of $2.016, which is subject to adjustment in certain circumstances (see Footnote 1)."}],"derivative":{"expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":49604},"source":{"system":"sec-edgar","filing":"0001209191-18-040510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118040510/doc4.xml","form_type":"4"}},{"id":3894432,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T21:31:31.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":14.24,"exercise_date":"2018-12-31","expiration_date":"2025-06-12","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-037810","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919118037810/doc4.xml","form_type":"4"}},{"id":4108399,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true}}],"security":"Stock Options","published_at":"2018-01-04T22:22:28.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":6061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2018 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":6061,"derivative":{"exercise_price":4.95,"exercise_date":"2019-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":6061},"source":{"system":"sec-edgar","filing":"0001654954-18-000107","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000165495418000107/section16.xml","form_type":"4"}},{"id":4308635,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-23T22:11:18.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The\ncorrect expiration date is May 12, 2025."}],"balance_after":6000,"derivative":{"exercise_price":5,"exercise_date":"2017-12-31","expiration_date":"2025-05-12","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-034740","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919117034740/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-19"}},{"id":4308634,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-23T22:11:18.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The\ncorrect expiration date is May 12, 2025."}],"balance_after":6000,"derivative":{"exercise_price":5,"exercise_date":"2017-05-12","expiration_date":"2025-05-12","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-034740","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919117034740/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-19"}},{"id":4312169,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-19T20:07:51.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":5,"exercise_date":"2017-05-12","expiration_date":"2022-05-12","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-033918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919117033918/doc4.xml","form_type":"4"}},{"id":4312168,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2017-05-19T20:07:51.000Z","date":"2017-05-12","kind":"exercise","acquired":false,"price":0,"reported_value":27196,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The principal amount of, and accrued interest on, the Convertible Promissory Note converted into shares of Common Stock of the Issuer at a\nconversion price of $1.40 per share immediately prior to the consummation of the Issuer's initial public offering."}],"derivative":{"exercise_price":1.4,"expiration_date":"2017-05-12","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001209191-17-033918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919117033918/doc4.xml","form_type":"4"}},{"id":4312167,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":33202,"kind":"person","name":"DIGIANDOMENICO ANTHONY","position":1,"cik":"0001083544","reported_name":"DIGIANDOMENICO ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-19T20:07:51.000Z","date":"2017-05-12","kind":"exercise","acquired":true,"shares":19426,"price":1.4,"value":27196.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of Common Stock were issued upon the conversion of the Convertible Promissory Note, as described in footnote (2)."}],"balance_after":58625,"source":{"system":"sec-edgar","filing":"0001209191-17-033918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083544/000120919117033918/doc4.xml","form_type":"4"}}]}